Page last updated: 2024-09-04

gadofosveset trisodium and Liver Neoplasms

gadofosveset trisodium has been researched along with Liver Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, HMC; Coburn, N; Karanicolas, PJ; Law, C; Milot, L1
Bannas, P; Hernando, D; Holmes, JH; Motosugi, U; Rahimi, MS; Reeder, SB1
Bannas, P; Bookwalter, CA; Motosugi, U; Munoz Del Rio, A; Nagle, SK; Potretzke, TA; Reeder, SB; Ziemlewicz, T1
Cheung, HM; Coburn, N; Karanicolas, PJ; Law, C; Milot, L; Shoichet, M1
Beuf, O; Leporq, B; Pilleul, F1
Foster, L; Haider, M; Law, C; McGregor, C; Milot, L1

Reviews

1 review(s) available for gadofosveset trisodium and Liver Neoplasms

ArticleYear
Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay.
    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2016, Volume: 67, Issue:3

    Topics: Adenocarcinoma; Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Gadolinium; Hemangioma; Humans; Hyperplasia; Kidney Neoplasms; Liver Neoplasms; Magnetic Resonance Imaging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms

2016

Trials

1 trial(s) available for gadofosveset trisodium and Liver Neoplasms

ArticleYear
Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.
    Journal of magnetic resonance imaging : JMRI, 2012, Volume: 36, Issue:3

    Topics: Contrast Media; Female; Fibrosis; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Sensitivity and Specificity

2012

Other Studies

4 other study(ies) available for gadofosveset trisodium and Liver Neoplasms

ArticleYear
Late Gadolinium Hyperintensity of Suspected Colorectal Liver Metastases on Gadofosveset-Enhanced Magnetic Resonance Imaging: A Predictor of Benignity and a Potential Problem-Solving Tool.
    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 2019, Volume: 70, Issue:3

    Topics: Adult; Aged; Clinical Decision-Making; Colorectal Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Reproducibility of Results

2019
Combined gadoxetic acid and gadofosveset enhanced liver MRI: A feasibility and parameter optimization study.
    Magnetic resonance in medicine, 2016, Volume: 75, Issue:1

    Topics: Adult; Contrast Media; Drug Combinations; Drug Synergism; Feasibility Studies; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Young Adult

2016
Combined gadoxetic acid and gadofosveset enhanced liver MRI for detection and characterization of liver metastases.
    European radiology, 2017, Volume: 27, Issue:1

    Topics: Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Retrospective Studies; ROC Curve

2017
[Perfusion MR imaging of the liver with a vascular contrast agent].
    Journal de radiologie, 2011, Volume: 92, Issue:3

    Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Angiography; Metabolic Clearance Rate; Models, Theoretical; Neovascularization, Pathologic; Organometallic Compounds; Regional Blood Flow; Sensitivity and Specificity

2011